A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)γa as a pancreatic beta cell-specific biomarker

Diabetologia

Volumn 53, Issue 7, 2010, Pages 1372-1383

  Flamez, D ^a   Roland, I ^b   Berton, A ^b   Kutlu, B ^c   Dufrane, D ^d   Beckers, M C ^e   De Waele, E ^f   Rooman, I ^f   Bouwens, L ^f   Clark, A ^g   Lonneux, M ^d   Jamar, J F ^d   Goldman, S ^a   Marechal D ^e   Goodman, N ^c   Gianello, P ^d   Van Huffel, C ^h   Salmon, I ^b   Eizirik, D L ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e EUROGENTEC S A   (Belgium)

^f VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^g CHURCHILL HOSPITAL   (United Kingdom)

^h BioWin   (Belgium)

Author keywords

Beta cell biomarkers; Diabetes; Functional genomics; Imaging; Pancreatic beta cells

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BIOLOGICAL MARKER; FXYD DOMAIN CONTAINING ION TRANSPORT REGULATOR 2; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHILD; CONTROLLED STUDY; DEVELOPMENTAL STAGE; ENZYME SUBUNIT; FETUS; FUNCTIONAL GENOMICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MACACA; MASSIVE PARALLEL SIGNAL SEQUENCING; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT; SCHOOL CHILD; SCREENING TEST; TISSUE MICROARRAY; VALIDATION STUDY;

ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DIABETES MELLITUS, TYPE 1; GENOMICS; HUMANS; IMMUNOHISTOCHEMISTRY; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MACACA; SODIUM-POTASSIUM-EXCHANGING ATPASE; TISSUE ARRAY ANALYSIS;

EID: 77955629622     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1714-z     Document Type: Article

References (39)

1. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC (2003) Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110.
2. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC (2008) Pancreatic beta-cell mass in European subjects with type 2 diabetes. Diabetes Obes Metab 10:32-42.
3. Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54:S97-S107.
4. Martinic MM, von Herrath MG (2008) Real-time imaging of the pancreas during development of diabetes. Immunol Rev 221:200-213.
5. Sweet IR, Cook DL, Lernmark A, Greenbaum CJ, Krohn KA (2004) Non-invasive imaging of beta cell mass: a quantitative analysis. Diabetes Technol Ther 6:652-659.
6. Sweet IR, Cook DL, Lernmark A et al (2004) Systematic screening of potential beta-cell imaging agents. Biochem Biophys Res Commun 314:976-983.
7. Gotthardt M, Lalyko G, van Eerd-Vismale J et al (2006) A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents. Regul Pept 137:162-167.
8. Wild D, Béhé M, Wicki A et al (2006) [Lys40(Ahx-DTPA-111In) NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting. J Nucl Med 47:2025-2033.
9. Kung MP, Hou C, Lieberman BP et al (2008) In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus. J Nucl Med 49:1171-1176.
10. Harris PE, Ferrara C, Barba P, Polito T, Freeby M, Maffei A (2008) VMAT2 gene expression and function as it applies to imaging beta-cell mass. J Mol Med 86:5-16.
11. Simpson NR, Souza F, Witkowski P et al (2006)Visualizing pancreatic beta-cell mass with [11C]DTBZ. Nucl Med Biol 33:855-864.
12. Souza F, Simpson N, Raffo A et al (2006) Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model. J Clin Invest 116:1506-1513.
13. Saisho Y, Harris PE, Butler AE et al (2008) Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas. J Mol Histol 39:543-551.
14. Ladrière L, Malaisse-Lagae F, Alejandro R, Malaisse WJ (2001) Pancreatic fate of a (125)I-labelled mouse monoclonal antibody directed against pancreatic B cell surface ganglioside(s) in control and diabetic rats. Cell Biochem Funct 19:107-115.
15. Murthy R, Harris P, Simpson N et al (2008) Whole body [11C]-dihydrotetrabenazine imaging of baboons: biodistribution and human radiation dosimetry estimates. Eur J Nucl Med Mol Imaging 35:790-797.
16. Goland R, Freeby M, Parsey R et al (2009) 11C-Dihydrotetrabenazine PETof the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med 50:382-389.
17. Sweadner KJ, Arystarkhova E, Donnet C, Wetzel RK (2003) FXYD proteins as regulators of the Na, K-ATPase in the kidney. Ann N Y Acad Sci 986:382-387.
18. Li C, Grosdidier A, Crambert G, Horisberger JD, Michielin O, Geering K (2004) Structural and functional interaction sites between Na, K-ATPase and FXYD proteins. J Biol Chem 279:38895-38902.
19. Wetzel RK, Pascoa JL, Arystarkhova E (2004) Stress-induced expression of the gamma subunit (FXYD2) modulates Na, KATPase activity and cell growth. J Biol Chem 279:41750-41757.
20. Dufrane D, van Steenberghe M, Guiot Yet al (2006) Streptozotocininduced diabetes in large animals (pigs/primates): role of GLUT2 transporter and beta-cell plasticity. Transplantation 81:36-45.
21. Kutlu B, Burdick D, Baxter D et al (2009) Detailed transcriptome atlas of the pancreatic beta cell. BMC Med Genomics 2:3.
22. Jongeneel CV, Delorenzi M, Iseli C et al (2005) An atlas of human gene expression from massively parallel signature sequencing (MPSS). Genome Res 15:1007-1014.
23. Krogh A, Larsson B, von Heijne G, Sonnhammer ELL (2001) Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305:567-580.
24. Gusev Y (2008) Computational methods for analysis of cellular functions and pathways collectively targeted by differentially expressed microRNA. Methods 44:61-72.
25. Eizirik DL, Moore F, Flamez D, Ortis F (2008) Use of a systems biology approach to understand pancreatic beta-cell death in type 1 diabetes. Biochem Soc Trans 36:321-327.
26. Cardozo AK, Kruhoffer M, Leeman R, Orntoft T, Eizirik DL (2001) Identification of novel cytokine-induced genes in pancreatic beta-cells by high-density oligonucleotide arrays. Diabetes 50:909-920.
27. Cardozo AK, Heimberg H, Heremans Y et al (2001) A comprehensive analysis of cytokine-induced and nuclear factor-κ B-dependent genes in primary rat pancreatic beta-cells. J Biol Chem 276:48879-48886.
28. Rasschaert J, Liu D, Kutlu B et al (2003) Global profiling of double stranded RNA- and IFN-γ-induced genes in rat pancreatic beta cells. Diabetologia 46:1641-1657.
29. D'Hertog W, Overbergh L, Lage K et al (2007) Proteomic analysis of cytokine-induced dysfunction and death in insulinproducing INS-1E cells: new insights into the pathways involved. Mol Cell Proteomics 6:2180-2199.
30. Smink LJ, Helton EM, Healy BC et al (2005) T1DBase, a community web-based resource for type 1 diabetes research. Nucleic Acids Res 33:D544-D549.
31. Ylipaasto P, Kutlu B, Rasilainen S et al (2005) Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia 48:1510-1522.
32. Kutlu B, Cardozo AK, Darville MI et al (2003) Discovery of gene networks regulating cytokine-induced dysfunction and apoptosis in insulin-producing INS-1 cells. Diabetes 52:2701-2719.
33. Rasschaert J, Ladrière L, Urbain M et al (2005) Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+interferon-ginduced apoptosis in primary pancreatic beta-cells. J Biol Chem 280:33984-33991.
34. Jones DH, Golding MC, Barr KJ, Fong GH, Kidder GM (2001) The mouse Na+-K + -ATPase gamma-subunit gene (Fxyd2) encodes three developmentally regulated transcripts. Physiol Genomics 6:129-135.
35. Maffei A, Liu Z, Witkowski P et al (2004) Identification of tissuerestricted transcripts in human islets. Endocrinology 145:4513-4521.
36. Gurkan C, Lapp H, Hogenesch JB, Balch WE (2005) Exploring trafficking GTPase function by mRNA expression profiling: use of the SymAtlas web-application and the Membrome datasets. Methods Enzymol 403:1-10.
37. Sha Q, Pearson W, Burcea LC et al (2008) Human FXYD2 G41R mutation responsible for renal hypomagnesemia behaves as an inward-rectifying cation channel. Am J Physiol Renal Physiol 295:F91-F98.
38. Capasso JM, Rivard CJ, Berl T (2006) Silencing and over-expression of the gamma-subunit of Na-K-ATPase directly affect survival of IMCD3 cells in response to hypertonic stress. Am J Physiol Renal Physiol 291:F1142-F1147.
39. Adalat S, Woolf AS, Johnstone KA et al (2009) HNF1B mutations associate with hypomagnesemia and renal magnesium wasting. J Am Soc Nephrol 20:1123-1131.